Avai Bio, Inc.
AVAI· OTC
Filed Aug 12, 2025 · 10-Q · 43 days after period end · 0001740797-25-000043
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$487.59K | -$528.84K | -$411.52K | $396.33K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d after period end